NO20013000L - Nye <beta>-amid- og <beta>-sulfonamidkarboksylsyrederivater, deres fremstilling og anvendelse som endotelinreseptorantagonister - Google Patents
Nye <beta>-amid- og <beta>-sulfonamidkarboksylsyrederivater, deres fremstilling og anvendelse som endotelinreseptorantagonisterInfo
- Publication number
- NO20013000L NO20013000L NO20013000A NO20013000A NO20013000L NO 20013000 L NO20013000 L NO 20013000L NO 20013000 A NO20013000 A NO 20013000A NO 20013000 A NO20013000 A NO 20013000A NO 20013000 L NO20013000 L NO 20013000L
- Authority
- NO
- Norway
- Prior art keywords
- beta
- carboxylic acid
- amide
- acid derivatives
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/22—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to two ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19858779A DE19858779A1 (de) | 1998-12-18 | 1998-12-18 | Neue ß-Amido und ß-Sulfonamidocarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
| PCT/EP1999/009679 WO2000037450A1 (de) | 1998-12-18 | 1999-12-09 | NEUE β-AMIDO- UND β-SULFONAMIDOCARBONSÄUREDERIVATE, IHRE HERSTELLUNG UND VERWENDUNG ALS ENDOTHELIN-REZEPTORANTAGONISTEN |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20013000D0 NO20013000D0 (no) | 2001-06-15 |
| NO20013000L true NO20013000L (no) | 2001-08-15 |
Family
ID=7891778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20013000A NO20013000L (no) | 1998-12-18 | 2001-06-15 | Nye <beta>-amid- og <beta>-sulfonamidkarboksylsyrederivater, deres fremstilling og anvendelse som endotelinreseptorantagonister |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1140867A1 (zh) |
| JP (1) | JP2002533330A (zh) |
| KR (1) | KR20010101279A (zh) |
| CN (1) | CN1334806A (zh) |
| AR (1) | AR023353A1 (zh) |
| AU (1) | AU3036400A (zh) |
| BG (1) | BG105618A (zh) |
| BR (1) | BR9916331A (zh) |
| CA (1) | CA2355251A1 (zh) |
| CZ (1) | CZ20012186A3 (zh) |
| DE (1) | DE19858779A1 (zh) |
| HK (1) | HK1042095A1 (zh) |
| HU (1) | HUP0201321A3 (zh) |
| IL (1) | IL143451A0 (zh) |
| NO (1) | NO20013000L (zh) |
| SK (1) | SK8682001A3 (zh) |
| TR (1) | TR200101780T2 (zh) |
| WO (1) | WO2000037450A1 (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0301892A3 (en) * | 2000-11-17 | 2005-06-28 | Warner Lambert Company Llc Mor | Pharmaceutical compositions for treatment of sexual dysfunction and their preparation |
| US7790770B2 (en) * | 2005-11-23 | 2010-09-07 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| EP2712865B1 (en) * | 2009-07-10 | 2016-03-16 | Cadila Healthcare Limited | Improved process for the preparation of ambrisentan |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8912700D0 (en) * | 1989-06-02 | 1989-07-19 | Shell Int Research | Herbicidal compounds |
| DE4329911A1 (de) * | 1993-09-04 | 1995-03-09 | Basf Ag | Substituierte Milchsäurederivate mit einem N-organischen Rest in beta-Position |
| TR199901416T2 (xx) * | 1996-12-18 | 1999-08-23 | Basf Aktiengesellschaft | Heterosiklik karbonikasit t�revleri. |
| DE19726146A1 (de) * | 1997-06-19 | 1998-12-24 | Basf Ag | Neue ß-Amino und ß-Azidopcarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
-
1998
- 1998-12-18 DE DE19858779A patent/DE19858779A1/de not_active Withdrawn
-
1999
- 1999-12-09 CA CA002355251A patent/CA2355251A1/en not_active Abandoned
- 1999-12-09 BR BR9916331-4A patent/BR9916331A/pt not_active Application Discontinuation
- 1999-12-09 KR KR1020017007615A patent/KR20010101279A/ko not_active Application Discontinuation
- 1999-12-09 TR TR2001/01780T patent/TR200101780T2/xx unknown
- 1999-12-09 CN CN99814580A patent/CN1334806A/zh active Pending
- 1999-12-09 JP JP2000589522A patent/JP2002533330A/ja active Pending
- 1999-12-09 EP EP99964533A patent/EP1140867A1/de not_active Withdrawn
- 1999-12-09 AU AU30364/00A patent/AU3036400A/en not_active Abandoned
- 1999-12-09 IL IL14345199A patent/IL143451A0/xx unknown
- 1999-12-09 WO PCT/EP1999/009679 patent/WO2000037450A1/de not_active Application Discontinuation
- 1999-12-09 SK SK868-2001A patent/SK8682001A3/sk unknown
- 1999-12-09 HU HU0201321A patent/HUP0201321A3/hu unknown
- 1999-12-09 CZ CZ20012186A patent/CZ20012186A3/cs unknown
- 1999-12-17 AR ARP990106523A patent/AR023353A1/es unknown
-
2001
- 2001-06-15 NO NO20013000A patent/NO20013000L/no not_active Application Discontinuation
- 2001-06-18 BG BG105618A patent/BG105618A/xx unknown
-
2002
- 2002-05-31 HK HK02104116.9A patent/HK1042095A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE19858779A1 (de) | 2000-06-21 |
| HUP0201321A3 (en) | 2003-02-28 |
| IL143451A0 (en) | 2002-04-21 |
| JP2002533330A (ja) | 2002-10-08 |
| BG105618A (en) | 2002-01-31 |
| WO2000037450A1 (de) | 2000-06-29 |
| HUP0201321A2 (hu) | 2002-12-28 |
| CA2355251A1 (en) | 2000-06-29 |
| AU3036400A (en) | 2000-07-12 |
| EP1140867A1 (de) | 2001-10-10 |
| SK8682001A3 (en) | 2002-08-06 |
| TR200101780T2 (tr) | 2001-11-21 |
| CZ20012186A3 (cs) | 2002-07-17 |
| BR9916331A (pt) | 2001-09-11 |
| HK1042095A1 (zh) | 2002-08-02 |
| AR023353A1 (es) | 2002-09-04 |
| CN1334806A (zh) | 2002-02-06 |
| NO20013000D0 (no) | 2001-06-15 |
| KR20010101279A (ko) | 2001-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0894084T3 (da) | Kanelsyrederivater og deres anvendelse som integrinantagonister | |
| HRP20010514B1 (en) | Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament | |
| DE60226469D1 (de) | Biphenylkarbonsäureamidderivate als p38 kinase-inhibitoren | |
| NO20025821L (no) | 2-aminokarbonyl-9H-purinderivater | |
| NO20070532L (no) | Substituerte 2-alkyl-kinazolinonderivater som PARP-inhibitorer | |
| ATE286500T1 (de) | 1,2,3,4-tetrahydroisochinolin-derivate | |
| DE60322359D1 (de) | Imidazopyridinderivate als kinaseinhibitoren | |
| NO20006282L (no) | Nye cyklosporiner | |
| DK0891325T3 (da) | Para-substituerede phenylpropansyrederivater som integrinantagonister | |
| NO20055219L (no) | Nye forbindelser | |
| DE69705829D1 (de) | Meta-substituierte phenylsulphonamidderivate | |
| TR200101155T2 (tr) | 4-Aroil Piperidin CCR-3 Reseptör Antagonistleri III | |
| NO991761L (no) | Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse | |
| NO20052520L (no) | Nye sulfamider | |
| ES2139760T3 (es) | Nuevas lactamas sustituidas con 4-piperidinilo con propiedades antagonistas del receptor de neurokinina 2 en el tratamiento del asma. | |
| NO975975L (no) | Vitronektinreseptor-antagonister, fremstilling samt anvendelse derav | |
| NO20063324L (no) | 3-cyano-kinolinderivater med antiproliferativ aktivitet | |
| HRPK20040372B3 (en) | Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist | |
| NO984861L (no) | Piperidiner og pyrrolidiner | |
| NO20002124L (no) | Nye karboksylsyrederivater med amid-sidekjeder, deres fremstilling og anvendelse som endothelin-reseptorantagonister | |
| NO20013000L (no) | Nye <beta>-amid- og <beta>-sulfonamidkarboksylsyrederivater, deres fremstilling og anvendelse som endotelinreseptorantagonister | |
| NO20020644L (no) | Nye integrinreseptor-antagonister | |
| NO20001934L (no) | 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse | |
| NO20013709D0 (no) | Nye N-triazolylmetyl-piperazinderivater som neurokininreseptorantagonister | |
| HRP20010630B1 (en) | 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |